Delivery Order SPE2DB22D1202-SPE2DB25FVCQ0
- Not listed
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Oxcarbazepine 300 mg/5 ml suspension in 250 ml quantities, with a ceiling value of $1,216.72 and a firm fixed price structure. The delivery order is scheduled for completion by September 22, 2025, with performance taking place at the company's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,008.18 firm fixed-price delivery order on August 25, 2025, for Oxcarbazepine 300 mg/5 ml suspension in a 250 ml container. This is a non-set-aside contract with an ultimate completion date of August 26, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $1,958.79 to AmerisourceBergen Drug Corp for the supply of Oxcarbazepine 300 mg/5 mL suspension in 250 mL quantities. The contract is a firm fixed price delivery order with no set-aside designation, competitively awarded on September 3, 2025, with an ultimate completion date of September 4, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- On September 3, 2025, the Defense Logistics Agency awarded a delivery order valued at $3,791.77 to AmerisourceBergen Drug Corp for the supply of Oxcarbazepine 300 mg/5 ml suspension in 250 ml quantities. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Oxcarbazepine 300 mg/5 ml suspension in 250ml quantities, with a ceiling value of $1,442.97. This firm fixed-price delivery order, with an ultimate completion date of May 13, 2025, represents a non-competitive set-aside and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,088 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oxcarbazepine 300 mg/5 mL suspension (250 mL), a neurological medication commonly used to treat seizure disorders and neuropathic pain. The contract, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-competitive set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support...
- This delivery order, awarded September 18, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of Oxcarbazepine 300 mg/5 ml suspension in a 250 ml quantity with a ceiling value of $1,125.28. The award is unset-aside and competitively awarded under a firm fixed price structure, with an ultimate completion date of September 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,025.75, is for the delivery of 4564543492 - Oxcarbazepine 300 mg/5 ml suspension, 250 ml. The contract has an ultimate completion date of May 9, 2024 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles, with a ceiling value of $2,874.78 and a period of performance through April 1, 2025. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation. AmerisourceBergen holds a significant Indefinite...
- The Defense Logistics Agency awarded a $1,161 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 250mL of Oxcarbazepine 300mg/5mL suspension. As a prime contractor on an indefinite delivery/indefinite quantity pharmaceuticals contract, Amerisourcebergen will deliver the generic anti-seizure medication to a facility in Conshohocken, Pennsylvania by June 27, 2023 to support the Department of Defense's medical supply needs. No subcontractors or set aside designations were...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVCQ0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,736.37 to AmerisourceBergen Drug Corp for Oxcarbazepine 300 mg/5 mL suspension in 250 mL quantities. The contract, executed on June 18, 2025, with an ultimate completion date of June 20, 2025, utilizes firm fixed price terms with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under a larger federal vehicle supporting the Defense Logistics Agency's pharmaceutical supply operations. This award is executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, and medical supplies to military healthcare systems worldwide. Oxcarbazepine, a neurological medication, aligns with the contractor's established portfolio of therapeutic products delivered through the Defense Health Agency and other federal healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated capability to fulfill federal medical procurement requirements through competitive award processes across multiple product categories and transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 6/18/25 |